SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-24-003640
Filing Date
2024-03-20
Accepted
2024-03-20 17:20:54
Documents
18
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A capr-20240514xpre14a.htm   iXBRL PRE 14A 880099
2 GRAPHIC capr-20240514xpre14a002.jpg GRAPHIC 8333
3 GRAPHIC capr-20240514xpre14a009.jpg GRAPHIC 31833
4 GRAPHIC capr-20240514xpre14a010.jpg GRAPHIC 31947
  Complete submission text file 0001558370-24-003640.txt   1658688

Data Files

Seq Description Document Type Size
5 EX-101.SCH capr-20240514.xsd EX-101.SCH 5771
6 EX-101.DEF capr-20240514_def.xml EX-101.DEF 6926
7 EX-101.LAB capr-20240514_lab.xml EX-101.LAB 14378
8 EX-101.PRE capr-20240514_pre.xml EX-101.PRE 7033
21 EXTRACTED XBRL INSTANCE DOCUMENT capr-20240514xpre14a_htm.xml XML 166019
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34058 | Film No.: 24768644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)